Signant Health Executive and Leadership Team

Krishna Maridi, the Chief Financial Officer at Signant Health, directs the financial planning, analysis, and fiscal strategy for the entire software organization. Overseeing capital allocation and investment in new eCOA and IRT technologies, the Chief Financial Officer ensures long-term economic stability. This leadership role involves managing complex budgetary requirements for global operations, including expansion into emerging clinical research markets. By monitoring key performance indicators, Maridi provides the executive team with critical insights into revenue growth and cost efficiency. The Chief Financial Officer maintains rigorous compliance with financial regulations while supporting the company's strategic objectives. Krishna Maridi evaluates potential partnerships and acquisitions to strengthen the firm's market position. Through disciplined fiscal management, the Chief Financial Officer enables the organization to invest in cutting-edge software development, ultimately supporting the delivery of high-quality data solutions to the global clinical trial industry.

Graciela Racaro, the Chief Operating Officer at Signant Health, directs all internal business processes and site-based eCOA service delivery. Overseeing global operational workflows, the Chief Operating Officer ensures seamless integration between software platforms and clinical trial sites. This leadership role involves optimizing supply chain management protocols to maintain high data integrity standards across North American and European markets. By streamlining cross-functional communication, Racaro improves project turnaround times for pharmaceutical partners. The Chief Operating Officer manages resource allocation to support complex, multi-site research initiatives. Graciela Racaro maintains rigorous quality control measures, ensuring every software deployment meets strict regulatory requirements. Through constant process refinement, the Chief Operating Officer drives operational excellence, allowing the organization to scale effectively while supporting the core mission of accelerating clinical development cycles for life sciences companies worldwide.

Scott Connor, the Chief Marketing Officer at Signant Health, architects the global brand strategy and market positioning for eConsent and data analytics solutions. Driving demand generation across international markets, the Chief Marketing Officer aligns messaging with the specific needs of biotech and pharmaceutical sponsors. This leadership role involves analyzing market trends to identify growth opportunities within the digital health landscape. By executing targeted campaigns, Connor expands the reach of the company's software portfolio. The Chief Marketing Officer collaborates with product teams to translate technical capabilities into compelling value propositions for clinical research stakeholders. Scott Connor manages the overarching brand identity, ensuring consistency across all digital channels and industry events. Through strategic market engagement, the Chief Marketing Officer secures a competitive advantage, positioning the organization as a leader in remote clinical trial technology and data-driven research support.

Edward Pollack, the Chief Technology Officer at Signant Health, architects the technical roadmap for all remote and site-based software solutions. Overseeing the engineering teams, the Chief Technology Officer drives innovation in eCOA, eConsent, and IRT platform development. This leadership role involves ensuring the scalability and security of data analytics infrastructure to meet the rigorous demands of global clinical trials. By implementing advanced software architectures, Pollack enhances the user experience for clinical site personnel and trial participants. The Chief Technology Officer collaborates with product management to integrate new features that address evolving industry challenges. Edward Pollack manages the technical debt and security protocols, protecting sensitive research data across all operational regions. Through continuous technological advancement, the Chief Technology Officer ensures the company remains at the forefront of digital health, providing robust, reliable, and compliant software tools for complex research environments.

Roopal Patel, the Senior Vice President of Biotech and Chief Revenue Officer Portfolio Delivery at Signant Health, directs revenue growth strategies specifically tailored for the biotech sector. Overseeing the delivery of the entire software portfolio, the Senior Vice President of Biotech and Chief Revenue Officer Portfolio Delivery ensures that client needs align with the company's technical capabilities. This leadership role involves managing high-value relationships with emerging biotech firms to drive adoption of eCOA and data analytics tools. By optimizing the revenue lifecycle, Patel secures long-term partnerships across diverse geographic regions. The Senior Vice President of Biotech and Chief Revenue Officer Portfolio Delivery coordinates with sales and operations to ensure seamless project execution. Roopal Patel identifies unique market requirements for smaller, agile research organizations, tailoring service delivery to maximize trial success. Through strategic revenue management, the Senior Vice President of Biotech and Chief Revenue Officer Portfolio Delivery sustains the company's growth trajectory.